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Available online 29 June 2019Background: Incisional hernia repair is the most common procedure after orthotopic liver transplantation. Al-
though enhanced recovery protocols are increasingly employed, the post–orthotopic liver transplantation pa-
tient may not benefit from all aspects of these models. The aim of the present study is to assess which
perioperative interventions and patient factors affect hospital length of stay in a cohort of post–orthotopic liver
transplantation patients undergoing incisional hernia repair.
Methods: We conducted a retrospective review of a series of adult patients undergoing incisional hernia repair
after orthotopic liver transplantation. The primary endpoint was length of stay. Results were stratified by demo-
graphic, intraoperative, and postoperative variables.
Results: Eleven percent (172/1523) of patientswho received orthotopic liver transplantation during the studype-
riod underwent subsequent incisional hernia repair. Median length of stay was 5 days (range 2–50). The stron-
gest predictor of length of stay was postoperative renal function. Despite liberal intraoperative administration of
volume (median 642mL/h) and brisk intraoperative urine output (median 72mL/h), postoperative acute kidney
injury occurred in 48% of patients. Those that developed acute kidney injury received less intraoperative volume
(6 vs 8.5 mL/kg/h; P= .031) and the severity of postoperative renal injury was inversely related to the amount
intraoperative volume given.
Conclusions: In patients undergoing incisional hernia repair after orthotopic liver transplantation, postoperative
renal function is frequently impaired. Although many aspects of current ERAS protocols may be applied to
post-transplant patients, restrictive intraoperative fluid administration strategies should be employed with cau-
tion given a high propensity for the development of post-operative acute kidney injury in this complex
population.
© 2019 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).BACKGROUND
Incisional hernias (IH) are a common complication following
orthotopic liver transplantation (OLT), with rates reported in the litera-
ture between 4.9 and 34.3% [3–19]. As one of themost frequent surgical
procedure after OLT, IH repair (IHR), provides a useful model for the
evaluation of transplant recipients' response to general surgical opera-
tions at large. Although the incidence of IHR after OLT is well described,
less attention has been afforded to the perioperative management of
this population within the literature.g of the American Society of
l of Medicine, Department of
apolis, IN 46202. Tel.: +1 317
. This is an open access article underEnhanced recovery after surgery (ERAS) pathways have recently
gained considerable attention across many surgical disciplines. Aimed
at reducing the derivative morbidity and cost associated with extended
hospital stay, these systems offer standardized guidelines for periopera-
tive management. From their inception in the 1990s, ERAS protocols
have been designed in a procedure-specific manner. Within abdominal
surgery, the ERAS society has published guidelines for operations ranging
from colon resection to pancreaticoduodenectomy. Among other things,
these strategies strive to avoid excess fluid administration, and have
even adopted the concept of ‘permissive oliguria.’ [1] Recently, patient-
specific variables such as advanced age [2], or emergent presentation,
have been found to affect the efficacy of enhanced recovery strategies.
As ERAS pathways are currently applied to an increasing variety general
surgical procedures, it will be important to consider their effects on
unique patient populations within these procedure-specific strategies;
unique patient populations deserve unique recovery strategies.
Patients livingwith ahepatic allograft exhibit uniqueneurohoromonal
stress responses; among other things, these patients exhibit an alteredthe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Table 1








Median time to hernia repair after OLT (d) 586 683 538 .04
Female 24.4% 17.8% 29.3% .09
Median Age at IHR (y) 55 56 53 .3
Median MELD at OLT 18 18 17 .4
Technique of Repair
Open Repair 35.5% 43.3% 56.7% .8
Laparoscopic Repair 64.5% 42.1% 57.9%
Albumin at IHR (mg/dL) 3.9 3.9 3.7 .03
BMI at IHR (kg/m2) 29.1 30.4 28.7 .02
Mesh size (cm2) 702 750 600 .1
EBL at IHR (mL) 30 50 30 .1
Length of IHR (min) 187.5 206 167 .005
Epidural anesthesia 32% 42.5% 25.3% .02
Return of bowel function (d) 3 4 3 .04
Intraoperative volume measures
Total volume (mL)
Volume given (mL/min) 10.7 10.6 10.7 .4
Intraoperative urine output (mL/min) 1.26 1.26 1.27 .1
Postoperative renal function
Median baseline Cr (mg/dL) 1 1 1 .2
Postoperative AKI⁎ 48.2% 71.2% 31.3% b.0001
Median peak Cr (mg/dL) 1.3 1.9 1.3 .0005
Rise in Cr 0.3% 0.9 0.27 b.0001
Postoperative liver function
Baseline bilirubin (mg/dL) 0.8 0.7 0.8 .06
Peak bilirubin (mg/dL) 1.5 1.6 1.5 .4
% Rise in bilirubin 89% 110% 77.8% .02
CKD, Chronic renal disease; HTN, hypertension; BMI, body mass index; IHR, incisional hernia repair; EBL, estimated blood loss.
⁎ Postoperative AKI defined as N0.3 mg/dL rise in Cr from baseline within 24 hours of operation.
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suscitation. Persistent depression of splanchnic vascular resistance,
coupledwith the nephrotoxicity of enterohepatic circulated immunosup-
pression agents, may predispose the native kidney to injury. Although
there are currently no enhanced recovery protocols designed for patients
with hepatic allografts undergoing subsequent surgery, it is likely that
many providers will begin utilizing available procedure-specific protocols
in this population; within this climate it important to carefully consider
the appropriateness of minimizing perioperative vascular preload.
The aim of the present study is to assess the effect of baseline demo-
graphic, and perioperative variables onmorbidity and hospital length of
stay in patientswhohave undergone IHR after OLT. Precedent to the an-
ticipated implementation of enhanced recovery protocols in this popu-
lation, specific attentionwas afforded to perioperative renal function, as
renal injury has well described implications to both graft and patient
survival after OLT.Table 2
Multivariable logistic regression of variables predicting increased length of hospital stay
Variable Odds ratio 95% CI P
Female 0.718 0.241–2.14 .553
MELD at OLT 0.972 0.892–1.056 .501
Laparoscopic Repair 0.916 0.331–2.536 .867
Preoperative Albumin 1.755 0.749–2.536 .201
BMI 1.054 0.961–1.156 .258
Mesh size 0.999 0.998–1.001 .763
EBL at IHR 1.001 0.997–1.005 .433
Length of Case (min) 1.004 0.997–1.012 .224
Epidural 3.191 1.100–9.252 .033
Days to bowel function 3.373 2.017–5.639 .001
Intraoperative urine output (mL/min) 0.799 0.515–1.238 .421
Baseline Serum Cr 0.755 0.221–2.570 .653
Postoperative AKI⁎ 2.786 1.129–6.879 .026
% rise in Bilirubin 1.112 0.826–1.495 .482
⁎ Postoperative Acute Kidney Injury (AKI) defined as N0.3 mg/dL rise in Cr from base-
line within 24 hours of operation.METHODS
This retrospective study was approved by the Indiana University
School of Medicine Institutional Review Board and was Health Insur-
ance Portability and Accountability Act (HIPPA)-compliant. We con-
ducted a review of a prospectively collected database consisting of all
patientswhounderwentOLT between the years of 2005–2016 at our in-
stitution. One hundred seventy-two such patients out of 1523OLTs per-
formed within the same period (172/1523, 11%) were identified as
having subsequently undergone IHR, all of whom are included in this
analysis. All repairs were performed by a single transplant surgeon
who specializes in hernia repair (J.A.P). Both laparoscopic and open re-
pairs were performed utilizing a synthetic mesh underlay approach.
The primary endpoint for this study was hospital length of stay fol-
lowing IHR. Secondary endpoints were the development of postopera-
tive morbidities. Perioperative fluid administered was specifically
queried; no patients in this studywere enrolled into protocoled volume
restriction pathways. Median hospital length of stay post-IHR was
5 days. Patients were stratified into two groups, those who required
hospital stays exceeding the 5 day median and those whose length of
stay was 5 days or less. Demographic and clinical variables were com-
pared between groups to assess for associations with the primary end-
point. Continuous variables were analyzed using the Wilcoxon-Mann–
Whitney test. Discrete variables were analyzed using the χ2 test.
Multivariable logistic regression of dichotomized length of stay
(N5 days versus b/= 5 days) was performed at .05 level of significance.
The factors that were included in themodel were gender, MELD, laparo-
scopic versus open procedure, preoperative serum albumin, BMI, mesh
size, blood loss, case length, use of epidural, days to return of bowel
function, intraoperative urine output, postoperative acute kidney injury,
baseline creatinine, and fraction bilirubin rise. Estimated adjusted odds
ratio with 95% confidence intervals were reported. The multivariable
analysis was done in Stata/SE 14.2 (Stata Statistical Software: Release
14. College Station, TX).
A secondary logistic regression analysis was conducted to assess for
whether or not statistically significant predictors of increased hospital
Fig 1. Postoperative renal function predicts length of hospital stay for incisional hernia repair after orthotopic liver transplantation. Despite a universally liberal intraoperative fluid
strategy, postoperative AKI occurred in 48% of patients. Those that developed AKI received less intraoperative volume (6 vs 8.5 mL/kg/min; P = .031) and the severity of postoperative
renal injury was inversely related to intraoperative volume (A). Intraoperative urine output was not effective at predicting postoperative AKI (B). The degree of renal injury was
directly related to length of stay (C); patients who developed AKI had a median stay of 8 days compared to 4 days in patients who did not (D).
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tions. Specifically,we sought to determinewhether or not postoperative
renal impairment was correlated in dependent fashion with volume of
crystalloid administered intraoperatively during IHR.
RESULTS
Eleven percent (172/1523) of patients who received OLT during the
years 2005 to 2016 subsequently underwent IHR. Table 1 summarizes
demographic and clinical features of the study cohort. The median
length of stay was 5 days (range 2–50). Considering an inflection
point at ≤5 days hospital stay, there were no statistically significant de-
mographic differences between long stays (n=73, 42%) and short stays
(n = 99, 58%). There was also no difference in hospital stays between
those who underwent open versus laparoscopic repairs.
In independent analysis, longer operative times, the use of thoracic
epidural catheters, delayed return of bowel function, increased BMI
and higher preoperative albumin were found to be associated with in-
creased length of hospital stay. Impaired liver graft function post-
operatively, as defined by increased serum bilirubin concentrations,and elevated INR also portended longer hospitalizations. In patients
whose lengths of stays exceeded 5 days (n = 73), bilirubin increased
by an average of 110% from baseline compared to 78% in patients with
shorter stays (P= .02). Of all collected perioperative variables, postop-
erative renal function was the most strongly associated with increased
length of stay (Table 1).
Median baseline creatinine (Cr) was identical between groups
(1 g/dL). In multivariate analysis, only the development of postopera-
tive acute kidney injury (AKI) (defined as a rise from baseline Cr con-
centrations of N0.3 mg/dL within 24 hours the IHR), epidural use, and
delayed return of bowel function, predicted a longer hospitalization
(Table 2). Furthermore, median peak Cr was significantly higher
among patientswith longer hospitalizations (1.9 vs 1.3 g/dL, P=.0005).
Median intraoperative fluid administration rates for the cohort were
642mL/h. (7mL/kg/h), andmedian intraoperative urine output was ro-
bust at 72 mL/h. Despite a universally liberal intraoperative fluid strat-
egy, postoperative AKI occurred in 83 patients (83/172, 48%). Those
that developed AKI received less intraoperative volume (6 vs
8.5 mL/kg/h; P = .031) and the severity of postoperative renal injury
was inversely related to intraoperative volume (Fig 1, A). Intraoperative
72 J.R. Butler et al. / Surgery Open Science 1 (2019) 69–73urine outputwas not effective at predicting postoperative AKI (Fig 1, B).
The degree of renal injury was directly related to length of hospital stay
(Fig 1, C); patients whodeveloped AKI had amedian stay of 8 days com-
pared to 4 days in patients who did not (Fig 1, D).
Discussion
The utilization of OLT is on the rise, and post-transplant survival con-
tinues to improve [20]. With this success, liver transplant patients rep-
resent an increasing population requiring non-transplant surgical care.
IHR is a common general surgical procedure performed after OLT, and
may therefore provide a useful model for the general perioperative
management of this cohort. As these procedures are increasingly per-
formed outside of a transplant center, it will be important for all in-
volved practitioners to consider the unique physiology that affects
postoperative outcome.
The recent success of ERAS protocols in reducing complications and
length of hospital stay make their application attractive to anesthesiol-
ogists and surgeons [21]. Of particular relevance to the current study,
these protocols focus on judicious intraoperative fluidmanagement. Al-
though from their inception, ERAS protocols recommend “goal directed
fluid management strategies” [22], there is little consensus as to what
constitutes appropriate goals or effective monitoring methods to assess
these goals [23]. In major abdominal surgeries or in the emergent set-
ting, invasive hemodynamic monitoring apparatuses (e.g., arterial line,
central venous or pulmonary artery pressuremeasurements, serial arte-
rial blood gasses) aid assessment of volume status and fluid responsive-
ness. However, such monitors are seldom used in routine elective
surgery, forcing practitioners to rely instead on predetermined volume
targets, urine output, and non-invasive pressure monitors to gauge in-
traoperative circulating volume [24]. In this scenario, a consensus state-
ment from the international enhanced recovery partnership champions
limiting intraoperative fluid administration to 2mL/kg/h. [25] Although
this may be applicable to a general surgical population, such an ap-
proach may prove harmful to patients with existing hepatic allografts
and deserves careful consideration.
Successful perioperative management of transplant patients re-
quires strict attention to allograft function. As shownwithin the present
dataset, some degree of allograft dysfunction is common after IHR. Even
moderate degrees of hepatic dysfunction can affect renal perfusion
through systemically altered vascular response [26]; decreased hepatic
metabolism causes a surplus of vasodilatory nitric oxide and endothelial
factors that decrease systemic vascular resistance and activate the
renin-angiotensin system [27,28]. Exacerbating this effect is a derivative
increase in splanchnic resistance. While typical surgical patients may
tolerate up to a 30% decrease in blood pressure without changes to sys-
temic blood pressure or heart rate, the splanchnic –and graft- perfusion
may be compromised with as little as 10% volume depletion. Therefore,
this marginal deficit escapes even stringent parameters of a goal di-
rected fluid strategy.
Potententiating the effects of excess systemic vasodiliatory media-
tors on renal perfusion is a patency of portosystemic collateral vessels
which are known to persist long after liver transplantation [29]. The re-
sultant splanchnic hyperkinetic circulation, coupled with the residual
low superior mesenteric artery (SMA) impedance after liver transplant
[30], can decrease renal perfusion despite a normal cardiac output.
Aside from challenging the conventionalmeasurements of goal directed
resuscitation, these regional perfusion aberrations create a potentially
double edged sword: activation of the renin-angiotensin system while
simultaneously shunting the effects of volume towards postoperative
ileus through the SMA, which itself may potentate nephrotoxicity of
conventional immunosuppressive agents that are enterohepaticly cir-
culated; daily monitoring of immunosuppression levels is paramount.
Limitations of the current study are (i) retrospective, (ii) single cen-
ter, (iii) and single-surgeon. However, these limitations may be rele-
gated by the large sample size; to date this represents the largestseries of hernia repairs after OLT. Furthermore, uniformity of operative
technique and postoperative management throughout this series likely
highlights effects of non-procedural perioperative variables, such as
renal function and intraoperative volume administration. Although a
randomized approach to the study of recovery pathways for this popu-
lation would be ideal, it is our contention that the present data
-although retrospective- should caution the application of perioperative
fluid restriction.
This study, which studied a large cohort of OLTs, demonstrates that
post-operative renal impairment is common in IHR after OLT. Likely a
multifactorial process, it is important to recognize that this occurred
even with a ‘liberal’ intraoperative volume strategy, and meticulous
postoperative immunosuppression adjustment. Furthermore, greater
intraoperative volume administration was associated with decreased
incidence of postoperative AKI, without extending length of hospital
stay within this population.
These findings have several important implications. First, it suggests
that traditional endpoints guiding intraoperative fluid administration
may not be useful in preventing kidney injury in OLT recipients under-
going subsequent general surgical operations. Second, since even a
fairly liberalfluid administration strategy did not protect against AKI de-
velopment, fluid restrictive strategies such as those advocated in ERAS
protocols may subject this unique population to increased risk for
renal impairment. Though such protocols have been shown to decrease
length of hospital stay in select populations, this effect is likely to bemit-
igated inOLT patients undergoing subsequent surgeries given their high
susceptibility to kidney injury.
In conclusion, patients undergoing IHR after OLT, postoperative
renal function is frequently impaired independent of intraoperative ve-
nous preload. Potentially owed to the enterohepatic circulation of neph-
rotoxic immunosuppression, this suggests an important perioperative
consideration for OLT patients undergoing general surgery procedures.
Although many aspects of current ERAS protocols may be applied to
post-transplant patients, restrictive intraoperative fluid administration
strategies should be employed with caution given a high propensity
for the development of post-operative AKI in this complex population.
Although prospective randomized assessment of ERAS protocols in pa-
tients with a hepatic allograft will be necessary, the current data sug-
gests that perioperative fluid restriction may not be an appropriate
component of such strategies.
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